Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 3:36 pm Purchase | 13G | Enveric Biosciences Inc. ENVB | ARMISTICE CAPITAL LLC | 273,109 9.990% | 273,109 (New Position) | View |
| 2024-02-06 10:17 am Sale | 13G | Enveric Biosciences Inc. ENVB | INTRACOASTAL CAPITAL LLC | 145,000 6.200% | -61,136 (-29.66%) | View |
| 2024-02-05 5:09 pm Unchanged | 13G | Enveric Biosciences Inc. ENVB | Hudson Bay Capital Management LP | 110,357 4.540% | 0 (Unchanged) | View |
| 2023-02-14 5:02 pm Purchase | 13G | Enveric Biosciences Inc. ENVB | AdvisorShares Trust | 116,295 5.600% | 116,295 (New Position) | View |
| 2023-02-08 06:06 am Purchase | 13G | Enveric Biosciences Inc. ENVB | INTRACOASTAL CAPITAL LLC | 206,136 9.400% | 206,136 (New Position) | View |
| 2023-02-07 4:28 pm Purchase | 13G | Enveric Biosciences Inc. ENVB | Hudson Bay Capital Management LP | 110,357 5.040% | 110,357 (New Position) | View |
| 2023-02-06 3:02 pm Purchase | 13G | Enveric Biosciences Inc. ENVB | ALPHA CAPITAL ANSTALT | 47,028 2.262% | 47,028 (New Position) | View |
| 2022-08-01 06:10 am Purchase | 13G | Enveric Biosciences Inc. ENVB | INTRACOASTAL CAPITAL LLC | 129,842 9.990% | 129,842 (New Position) | View |
| 2022-01-18 4:54 pm Purchase | 13G | Enveric Biosciences Inc. ENVB | ALPHA CAPITAL ANSTALT | 2,317,163 7.383% | 1,995,740 (+620.91%) | View |
| 2021-02-10 12:29 pm Purchase | 13G | Enveric Biosciences Inc. ENVB | TOP Invest LLC | 2,299,001 19.800% | 2,299,001 (New Position) | View |
| 2021-02-09 6:03 pm Unchanged | 13G | Enveric Biosciences Inc. ENVB | STEFANSKY DAVID | 1,147,915 9.990% | 0 (Unchanged) | View |
| 2021-01-19 5:16 pm Purchase | 13G | Enveric Biosciences Inc. ENVB | STEFANSKY DAVID | 1,147,915 9.990% | 1,147,915 (New Position) | View |
| 2021-01-12 4:42 pm Purchase | 13G | Enveric Biosciences Inc. ENVB | Chex Associates LLC | 882,790 7.620% | 882,790 (New Position) | View |
| 2021-01-12 3:51 pm Purchase | 13G | Enveric Biosciences Inc. ENVB | TAF Group LLC | 934,257 8.000% | 934,257 (New Position) | View |
| 2020-05-06 3:52 pm Purchase | 13G | Enveric Biosciences Inc. ENVB | ALPHA CAPITAL ANSTALT | 321,423 9.900% | 321,423 (New Position) | View |
| 2020-02-14 5:09 pm Sale | 13G | Enveric Biosciences Inc. ENVB | Anson Funds Management LP | 0 0.000% | -4,877,350 (Position Closed) | View |
| 2020-01-31 1:58 pm Unchanged | 13G | Enveric Biosciences Inc. ENVB | Hudson Bay Capital Management LP | 0 0.000% | 0 (Unchanged) | View |